Abstract:ConspectusClustered, regularly interspaced, short palindromic repeat (CRISPR)/associated protein 9 (CRISPR/Cas9) is emerging as a powerful genome-editing tool, enabling precise and targeted modifications of virtually any genomic sequence in living cells. These technologies have potential therapeutic applications for cancers, metabolic diseases, and genetic disorders. However, several major challenges hinder the full realization of their potential. Specifically, CRISPR-Cas9 gene editors, whether delivered as plasmid DNA, mRNA/sgRNA, or ribonucleoprotein (RNP), exhibit poor membrane permeability, restricting their access to the intracellular genome, where the editing occurs. Additionally, these editors lack tissue or organ specificity, raising concerns about off-target editing at the tissue level that causes unwanted genotoxicity. Though a range of delivery carriers has been developed to deliver Cas9 editors, their effectiveness is often limited by a number of barriers at both the extracellular and intracellular levels. Moreover, the prolonged activity of Cas9 increases the risk of off-target editing at the genomic level. Therefore, it is crucial to develop efficient delivery vectors, along with molecular switches to safely regulate Cas9 activity.In this Account, we summarize our recent achievements in developing different types of materials that can efficiently deliver the plasmid DNA encoding Cas9 protein and single-guide RNA (sgRNA), or Cas9 RNP into cells to highlight the design considerations of carriers for safe and efficient delivery in vitro and in vivo. After elucidating the chemical and physical factors that are responsible for encapsulating and delivering these biomacromolecules, we further elucidate how we design the biodegradable polymeric carriers using dynamic disulfide chemistry, emphasize their safe and efficient delivery features for genome-editing biomacromolecules, and also introduce the integration of the intracellular delivery of genome-editing biomacromolecules with microneedle-based transdermal delivery to promote therapeutic genome editing for inflammatory skin disorders. Finally, we review how we exploit optical, chemical, and genetic switches to control the Cas9 activity in conjunction with targeted delivery to address the spatiotemporal specificity of gene editing in vivo and demonstrate their precision therapy against cancer and colitis treatment as proof-of-concept examples. In the final part, we will summarize the progress we have made and propose the future directions that may impact the field based on our own research outcomes.

Improving transgene expression and CRISPR-Cas9 efficiency with molecular engineering-based molecules

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Modulating CRISPR/Cas9 genome-editing activity by small molecules

Improving the Efficiency of Precise Genome Editing with Site-Specific Cas9-oligonucleotide Conjugates

Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficacies

Non-Viral CRISPR/Cas Gene Editing in Vitro and in Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 Mrna and Sgrna.

Aptazyme-mediated Direct Modulation of Post-Transcriptional Sgrna Level for Conditional Genome Editing and Gene Expression.

Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Improving The Knock-In Efficiency Of The Mof-Encapsulated Crispr/Cas9 System Through Controllable Embedding Structures

Protein Engineering of DNA Targeting Type Ⅱ CRISPR/Cas Systems

Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications

Advances in the Engineering of the Gene Editing Enzymes and the Genomes: Understanding and Handling the Off-Target Effects of CRISPR/Cas9.

The application of CRISPR /Cas mediated gene editing in synthetic biology: Challenges and optimizations

Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing

Nano-vectors for CRISPR/Cas9-mediated genome editing

Lipids and Polymers Mediated CRISPR/Cas9 Gene Editing